Mark H. Pollack

Affiliations: 
Psyciatry Massachusetts General Hospital & Harvard Medical School, Boston, MA, United States 
Google:
"Mark Pollack"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Voigt RM, Zalta AK, Raeisi S, et al. (2022) Abnormal intestinal milieu in post-traumatic stress disorder is not impacted by treatment that improves symptoms. American Journal of Physiology. Gastrointestinal and Liver Physiology
Held P, Klassen BJ, Small CF, et al. (2020) A Case Report of Cognitive Processing Therapy Delivered over a Single Week. Cognitive and Behavioral Practice. 27: 126-135
Held P, Zalta AK, Smith DL, et al. (2020) Maintenance of treatment gains up to 12-months following a three-week cognitive processing therapy-based intensive PTSD treatment programme for veterans. European Journal of Psychotraumatology. 11: 1789324
Dowd SM, Zalta AK, Burgess HJ, et al. (2020) Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World Journal of Psychiatry. 10: 21-28
Lofgreen AM, Tirone V, Carroll KK, et al. (2020) Improving outcomes for a 3-week intensive treatment program for posttraumatic stress disorder in survivors of military sexual trauma. Journal of Affective Disorders. 269: 134-140
Zalta AK, Pinkerton LM, Valdespino-Hayden Z, et al. (2020) Examining Insomnia During Intensive Treatment for Veterans with Posttraumatic Stress Disorder: Does it Improve and Does it Predict Treatment Outcomes? Journal of Traumatic Stress
Tirone V, Smith D, Steigerwald VL, et al. (2020) Examining the Impact of Sexual Revictimization in a Sample of Veterans Undergoing Intensive PTSD Treatment. Journal of Interpersonal Violence. 886260519897333
Huffman JC, Pollack MH, Stern TA. (2020) Panic Disorder and Chest Pain: Mechanisms, Morbidity, and Management. Primary Care Companion to the Journal of Clinical Psychiatry. 4: 54-62
Rosenfield D, Smits JAJ, Hofmann SG, et al. (2019) Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis. Journal of Anxiety Disorders. 68: 102149
Hofmann SG, Papini S, Carpenter JK, et al. (2019) Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder. Plos One. 14: e0223729
See more...